Dasher Neuroscience Holdings (ROCO:7829) Other Current Receivables: NT$0.88 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7829 Dasher Neuroscience Holdings Inc ROCO:7829
12 GF Score
Price NT$39.60
! 2 Warning Signs
View Full Analysis

What is Dasher Neuroscience Holdings Other Current Receivables?

Dasher Neuroscience Holdings ROCO:7829 12 Other Current Receivables is NT$0.88 Mil as of Dec. 2025. GuruFocus rates ROCO:7829 with a GF Score™ of 12/100. The stock has 2 warning signs investors should review.

Dasher Neuroscience Holdings's Other Current Receivables for the quarter that ended in Dec. 2025 was NT$0.88 Mil.

Dasher Neuroscience Holdings's quarterly Other Current Receivables declined from Dec. 2024 (NT$2.31 Mil) to Jun. 2025 (NT$0.82 Mil) but then increased from Jun. 2025 (NT$0.82 Mil) to Dec. 2025 (NT$0.88 Mil).

Dasher Neuroscience Holdings's annual Other Current Receivables increased from Dec. 2023 (NT$1.25 Mil) to Dec. 2024 (NT$2.31 Mil) but then declined from Dec. 2024 (NT$2.31 Mil) to Dec. 2025 (NT$0.88 Mil).

Dasher Neuroscience Holdings Other Current Receivables Related Terms

Dasher Neuroscience Holdings Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Dasher Neuroscience Holdings's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dasher Neuroscience Holdings Other Current Receivables Chart

Dasher Neuroscience Holdings Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Other Current Receivables
0.06 1.25 2.31 0.88

Dasher Neuroscience Holdings Semi-Annual Data
Dec22 Dec23 Jun24 Dec24 Jun25 Dec25
Other Current Receivables Get a 7-Day Free Trial 1.25 0.00 2.31 0.82 0.88
ROCO:7829
12GF Score
Dasher Neuroscience Holdings Inc ROCO:7829
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dasher Neuroscience Holdings Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of NT$0.88 Mil mean?
Dasher Neuroscience Holdings (ROCO:7829) has a Other Current Receivables of NT$0.88 Mil as of Dec. 2025. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Dasher Neuroscience Holdings and its competitors.
Is Dasher Neuroscience Holdings' Other Current Receivables too high?
Dasher Neuroscience Holdings' current Other Current Receivables is NT$0.88 Mil. Overall, Dasher Neuroscience Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Dasher Neuroscience Holdings' Other Current Receivables compare to ZTS?
Dasher Neuroscience Holdings' Other Current Receivables of NT$0.88 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Drug Manufacturers company?
A good Other Current Receivables depends on the Drug Manufacturers industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Dasher Neuroscience Holdings and its competitors. Dasher Neuroscience Holdings's current Other Current Receivables is NT$0.88 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dasher Neuroscience Holdings stock overvalued right now?
Dasher Neuroscience Holdings (ROCO:7829) has a current Other Current Receivables of NT$0.88 Mil. The current Other Current Receivables is NT$0.88 Mil. Dasher Neuroscience Holdings' overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Dasher Neuroscience Holdings (ROCO:7829), the current Other Current Receivables is NT$0.88 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dasher Neuroscience Holdings Business Description

Address Park Street, 17th Floor., No.3, Nangang District, Taipei, TWN, 115603
Yoda Pharmaceuticals Inc is a pharmaceutical company specializing in using AI technology to develop drugs targeting Central Nervous System (CNS) disorders. The group provides solutions for Neurology, Neuropsychiatry, and Cerebrovascular Disease.
12GF Score

Get the complete analysis for ROCO:7829

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$39.60
Price